|
Variable
|
Number
|
|---|
|
Age, years (N = 23)
| |
|
<45
|
3
|
|
45–55
|
8
|
|
>55
|
12
|
|
Menopausal status (N = 23)
| |
|
Pre-/peri-menopausal
|
16
|
|
Post-menopausal
|
7
|
|
Tumor size (cm) (N = 23)
| |
|
<2
|
12
|
|
≥2
|
11
|
|
Nodal status (N = 22)
| |
|
Negative
|
11
|
|
Positive
|
11 (2 micrometasis)
|
|
Unknown
|
1
|
|
Tumor grade (SBR) (N = 20)
| |
|
I
|
9
|
|
II
|
9
|
|
III
|
2
|
|
Histology (N = 20)
| |
|
Ductal
|
16
|
|
Lobular
|
1
|
|
Other
|
3
|
|
ER status (N = 22)
| |
|
Positive
|
6
|
|
Negative
|
16
|
|
Unknown
|
1
|
|
PR status (N = 22)
| |
|
Positive
|
8
|
|
Negative
|
14
|
|
Unknown
|
1
|
|
HER-2 status (N = 21)
| |
|
Positive
|
20
|
|
Negative
|
1
|
|
Unknown
|
2
|
-
N = the number of specimens available for evaluation. ER, estrogen receptor; PR, progesterone receptor; SBR, Scarff, Blum, and Richardson.
